| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $34.9M | -13.2% | +26.6% |
| SG&A Expense | $7.9M | +4.5% | +220.9% |
| Operating Income | -$42.8M | +2.6% | -42.5% |
| Pre-tax Income | -$43.8M | +3.2% | -47.0% |
| Net Income | -$43.8M | +3.2% | -47.0% |
| EPS (Basic) | -$0.92 | +11.5% | -31.4% |
| EPS (Diluted) | -$0.92 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $74.3M | +60.2% | +489.1% |
| Short-term Investments | $380.7M | +212.0% | +51.4% |
| Current Assets | $475.5M | +159.7% | +74.5% |
| Total Assets | $476.0M | +159.3% | +74.3% |
| Current Liabilities | $38.8M | -2.9% | +47.4% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$116.9M | — | — |
| Capital Expenditures | $196K | — | — |
| Investing Cash Flow | -$167.5M | — | — |
| Financing Cash Flow | $336.1M | — | — |
| Free Cash Flow | -$117.1M | — | — |
| +11.5% |
| -31.4% |
| $137.2M |
| +29.9% |
| +30.9% |
| Total Liabilities | $359.0M | +157.9% | +191.1% |
| Stockholders' Equity | $117.0M | +163.6% | -21.9% |